Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. The company's products include Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder, Brovana (arformoterol tartrate) inhalation solution, Latuda (lurasidone HCI) and Aptiom (eslicarbazepine acetate).
Headquartered in Marlborough, Mass., Sunovion is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc.
If you currently work at this organization, click the “Do you work here?” button to request editing privileges.
This SponsorPitch page is about Sunovion and contains information about this organization's sponsorship activity, sponsorship decision makers and sponsorship preferences. This page is not endorsed by or affiliated with Sunovion, though it may be actively managed and updated by company representatives. If you currently work at this organization, click the Manage Sponsor button to request management privileges. . All trademarks, service marks and copyrights are property of their respective owners.
Please log in to access this feature. Don't have an account? Sign up today!